Nucleus Genomics has been courting controversy for years with products that claim to tell people how their genetics correlate to a host of complex issues, including their IQ.

“Nucleus has once again ranked Domo as a leader in the Analytics Value Matrix due to its ability to equip organizations with sophisticated end-to-end tools that help to create data products ...

NEW YORK, June 4, 2025 /PRNewswire/ -- With U.S. birthrates plummeting and IVF on the rise, Nucleus Genomics today launched Nucleus Embryo, the first genetic optimization software that lets ...

Nucleus Embryo is an important step toward complete data ownership for parents planning their families. "Before there's a heartbeat, there's DNA," said Kian Sadeghi, founder and CEO of Nucleus.

The study is part of Kokkonen's doctoral thesis and a direct scientific follow-up to her master's thesis, in which she discovered a new type of atomic nucleus, the 190-astatine. The thesis article ...

The antimalarial drug mefloquine could help treat genetic diseases such as cystic fibrosis, Duchenne muscular dystrophy, as well as some cancers. In these diseases, a mutation in the genetic code ...

Side effects Aminoglycosides can override the stop signal on their own, but this requires a very high dose, causing many side effects. As mefloquine boosts the efficiency of aminoglycosides, the ...

An expert briefly describes the study ‘Single Dose Aminoglycosides versus Carbapenems for the Treatment of Uncomplicated Urinary Tract Infections Caused by Extended-Spectrum β-lactamase ...

Now part of Red Nucleus, COEUS leverages the deep knowledge and experience of the company’s many subject matter experts. The company works on all drug types with a particular focus on gene and ...

How is Nucleus different? Genomic testing has always been fragmented— there are over 70,000 genetic tests on the market today, each analyzing different genes or markers. Our technology combines all ...

In addition to Nucleus’ facility at the Mayo Clinic in Rochester, Minnesota, these sites will bring radiopharmaceutical manufacturing capabilities to within a four-hour drive of 60% of the U.S ...

Pharma CDMO Nucleus RadioPharma links up with ARTBIO to help produce prostate cancer candidate for clinical trials By Fraiser Kansteiner May 7, 2024 8:47am ...